HealthEquity, Inc. $HQY Shares Acquired by AQR Capital Management LLC

AQR Capital Management LLC raised its stake in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 89.9% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 445,653 shares of the company's stock after purchasing an additional 210,972 shares during the quarter. AQR Capital Management LLC owned about 0.52% of HealthEquity worth $38,540,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. Invesco Ltd. raised its position in HealthEquity by 50.6% during the 1st quarter. Invesco Ltd. now owns 2,446,198 shares of the company's stock worth $216,171,000 after buying an additional 821,425 shares during the last quarter. Nuveen LLC acquired a new stake in shares of HealthEquity in the first quarter worth $53,076,000. Price T Rowe Associates Inc. MD raised its holdings in shares of HealthEquity by 995.6% during the first quarter. Price T Rowe Associates Inc. MD now owns 639,345 shares of the company's stock worth $56,500,000 after purchasing an additional 580,988 shares during the last quarter. Westfield Capital Management Co. LP purchased a new position in shares of HealthEquity during the first quarter worth $49,787,000. Finally, Ameriprise Financial Inc. lifted its position in HealthEquity by 148.1% during the first quarter. Ameriprise Financial Inc. now owns 669,939 shares of the company's stock valued at $59,203,000 after purchasing an additional 399,897 shares during the period. 99.55% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other HealthEquity news, EVP Michael Henry Fiore sold 1,794 shares of the company's stock in a transaction on Monday, July 7th. The stock was sold at an average price of $101.73, for a total value of $182,503.62. Following the completion of the sale, the executive vice president directly owned 53,225 shares in the company, valued at $5,414,579.25. This represents a 3.26% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 1.50% of the stock is owned by company insiders.

HealthEquity Price Performance

Shares of NASDAQ HQY traded down $1.48 during trading on Wednesday, hitting $91.51. The company had a trading volume of 790,954 shares, compared to its average volume of 1,044,565. HealthEquity, Inc. has a fifty-two week low of $74.07 and a fifty-two week high of $116.65. The stock has a fifty day simple moving average of $93.94 and a two-hundred day simple moving average of $94.74. The company has a quick ratio of 4.23, a current ratio of 4.23 and a debt-to-equity ratio of 0.47. The firm has a market capitalization of $7.88 billion, a price-to-earnings ratio of 55.46, a price-to-earnings-growth ratio of 1.32 and a beta of 0.50.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on HQY shares. Deutsche Bank Aktiengesellschaft boosted their price objective on HealthEquity from $98.00 to $115.00 and gave the company a "buy" rating in a report on Thursday, June 5th. JMP Securities lifted their price target on HealthEquity from $110.00 to $117.00 and gave the company a "market outperform" rating in a research report on Wednesday, June 4th. The Goldman Sachs Group upped their price objective on HealthEquity from $94.00 to $104.00 and gave the stock a "neutral" rating in a research report on Wednesday, June 4th. Bank of America lifted their target price on shares of HealthEquity from $110.00 to $125.00 and gave the company a "buy" rating in a report on Wednesday, June 4th. Finally, Wall Street Zen upgraded shares of HealthEquity from a "hold" rating to a "buy" rating in a research note on Friday, June 6th. One analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat, HealthEquity currently has a consensus rating of "Buy" and a consensus target price of $119.77.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.